Your browser doesn't support javascript.
loading
Effect of Oral Administration of Bromelain on Postoperative Discomfort After Third Molar Surgery.
Ghensi, Paolo; Cucchi, Alessandro; Creminelli, Luca; Tomasi, Cristiano; Zavan, Barbara; Maiorana, Carlo.
Afiliação
  • Ghensi P; *Centre for Integrative Biology, University of Trento, Trento †Department of Biomedical and Neuromotorial Science, University of Bologna, Bologna ‡Department of Oral Surgery, Milan, Italy §Department of Periodontology, Institute of Odontology, The Sahlgrenska Academy at University of Gothenburg, Gothenborg, Sweden ||Department of Biomedical Sciences, University of Padova, Padova ¶Department of Implantology, University of Milan, IRCSS Cà Granda, Milan, Italy.
J Craniofac Surg ; 28(2): e191-e197, 2017 Mar.
Article em En | MEDLINE | ID: mdl-27755433
ABSTRACT

INTRODUCTION:

The purpose of this prospective randomized controlled clinical trial was to evaluate the effect of oral administration of bromelain on discomfort after mandibular third molar surgery. MATERIALS AND

METHODS:

Eighty-four consecutive patients requiring surgical removal of a single mandibular impacted third molar under local anesthesia were randomly assigned to receiving no drug (control group, Group A), postoperative 40 mg bromelain every 6 hours for 6 days (Group B), preoperative 4 mg dexamethasone sodium phosphate as a submucosal injection (Group C), and preoperative 4 mg dexamethasone sodium phosphate as a submucosal injection plus postoperative 40 mg bromelain every 6 hours for 6 days (Group D). Standardized surgical and analgesic protocols were adopted. Maximum interincisal distance and facial contours were measured at baseline and on postoperative days 2 and 7. Pain was measured objectively by counting the number of analgesic tablets required. Patient perception of the severity of symptoms was assessed with a follow-up questionnaire (PoSSe scale).

RESULTS:

On postoperative day 2, there was a statistically significant reduction in facial edema in both Groups C and D compared with the control group, but no statistically significant differences were observed between Group B and the control group. At evaluation on postoperative day 7, Group D showed a statistically significant reduction in postoperative swelling compared with the control group. The combined use of bromelain and dexamethasone (Group D) induced a statistically significant reduction in the total number of analgesic tablets taken after surgery compared with the control group. The treatment groups had a limited, nonsignificant effect on trismus when compared with the control group.

CONCLUSIONS:

Bromelain used singly showed moderate anti-inflammatory efficacy, reducing postoperative swelling, albeit not to any significant extent compared with no drug administration. The combined use of bromelain and dexamethasone sodium phosphate yielded the best results in terms of control of postoperative discomfort.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Dor Pós-Operatória / Extração Dentária / Dente Impactado / Bromelaínas / Anti-Inflamatórios / Dente Serotino Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Craniofac Surg Assunto da revista: ODONTOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Dor Pós-Operatória / Extração Dentária / Dente Impactado / Bromelaínas / Anti-Inflamatórios / Dente Serotino Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Craniofac Surg Assunto da revista: ODONTOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália